Sign in

CIK 0000914475 · Large accelerated filer

NEUROCRINE BIOSCIENCES INC

Sign in to watch
Ticker
NBIX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330525145
Phone
(858) 617-7600
Business address
6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,162,347
in 4 filings, $3.2M under 10b5-1 plans

Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. MORROW GEORGE J −$2.3M Director sold 59% of stake
  2. ABERNETHY MATT −$363K Chief Financial Officer sold 5% of stake
  3. BENEVICH ERIC −$333K Chief Commercial Officer sold 3% of stake
  4. Boyer David W. −$130K Chief Corp. Affairs Officer sold 9% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-13 ABERNETHY MATT Chief Financial Officer Option exercise 10b5-1 +2,566 36,127
2025-02-13 ABERNETHY MATT Chief Financial Officer Sale 10b5-1 −1,352 $116.85 $158K 34,775
2025-02-13 ABERNETHY MATT Chief Financial Officer Option exercise 10b5-1 +2,241 37,016
2025-02-13 ABERNETHY MATT Chief Financial Officer Sale 10b5-1 −1,206 $116.87 $141K 35,810
2025-02-13 ABERNETHY MATT Chief Financial Officer Option exercise · Restricted Stock Unit 10b5-1 −2,566 5,132
2025-02-13 ABERNETHY MATT Chief Financial Officer Option exercise · Restricted Stock Unit 10b5-1 −2,241 6,725
2025-02-12 Cooke Julie Chief Human Resources Officer Grant or award · Stock Option 10b5-1 +29,600 29,600
2025-02-12 Cooke Julie Chief Human Resources Officer Grant or award · Restricted Stock Unit 10b5-1 +5,548 5,548
2025-02-12 ROBERTS EIRY Chief Medical Officer Grant or award · Stock Option 10b5-1 +43,261 43,261
2025-02-12 ROBERTS EIRY Chief Medical Officer Grant or award · Restricted Stock Unit 10b5-1 +8,108 8,108
2025-02-12 Onyia Jude Chief Scientific Officer Grant or award · Stock Option 10b5-1 +54,645 54,645
2025-02-12 Onyia Jude Chief Scientific Officer Grant or award · Restricted Stock Unit 10b5-1 +10,241 10,241
2025-02-12 Lippoldt Darin Chief Legal Officer Gift 10b5-1 −190 41,489
2025-02-12 Lippoldt Darin Chief Legal Officer Grant or award · Stock Option 10b5-1 +38,252 38,252
2025-02-12 Lippoldt Darin Chief Legal Officer Grant or award · Restricted Stock Unit 10b5-1 +7,169 7,169
2025-02-12 Gano Kyle Chief Executive Officer Grant or award · Stock Option 10b5-1 +104,736 104,736
2025-02-12 Gano Kyle Chief Executive Officer Grant or award · Restricted Stock Unit 10b5-1 +19,628 19,628
2025-02-12 Delaet Ingrid Chief Regulatory Officer Grant or award · Stock Option 10b5-1 +34,153 34,153
2025-02-12 Delaet Ingrid Chief Regulatory Officer Grant or award · Restricted Stock Unit 10b5-1 +6,401 6,401
2025-02-12 Boyer David W. Chief Corp. Affairs Officer Grant or award · Stock Option 10b5-1 +34,153 34,153

Page 23 of 49 · 963 trades